Skip to content

Amophar OTC: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Amophar OTC

BE 0795.483.142
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€3,725
2024 · €170+€3,555
Equity
€15,024
2024 · €11,300+€3,724
Cash
€345
2024 · €29,364-€29,019
Balance sheet total
€272,827
2024 · €158,595+€114,232

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€169,090

    up €169,090 (+192%), from €88,000 to €257,090

    of which Other amounts receivable: +€121,950

  • Cash -€29,019

    down €29,019 (-98.8%), from €29,364 to €345

    mainly Receivables within one year (-€169,090) and Accrued charges and deferred income (-€125,433)

  • Stocks and contracts -€19,989

    down €19,989 (-56.5%), from €35,381 to €15,392

  • Deferred charges and accrued income -€5,850

    down €5,850 (-100%), from €5,850 to €0

Equity and liabilities
  • Trade debts +€235,291

    up €235,291 (+1,875%), from €12,547 to €247,838

  • Accrued charges and deferred income -€125,433

    down €125,433 (-100%), from €125,433 to €0

  • Profit (loss) carried forward +€3,724

    up €3,724 (+286%), from €1,300 to €5,024

Income statement
  • Gross operating margin +€6,006

    up €6,006, from -€1,718 to €4,288

  • Taxes +€1,299

    new in 2025: €1,299

  • Other operating charges +€707

    new in 2025: €707

  • Financial charges +€238

    up €238 (+83.8%), from €284 to €522

  • Financial income -€207

    down €207 (-9.5%), from €2,172 to €1,965

    of which Financial income: -€207

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €170
Gross operating margin +€6,006
Other operating charges -€707
Financial income -€207
Financial charges -€238
Taxes -€1,299
Result 2025 €3,725
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€29,018
Investment €0
Financing -€1
Cash 2024 €29,364
Net result for the year +€3,725
Stocks and contracts +€19,989
Receivables within one year -€169,090
Deferred charges and accrued income +€5,850
Trade debts +€235,291
Tax, wage and social debts +€650
Accrued charges and deferred income -€125,433
Contributions, distributions and other -€1
Cash 2025 €345
brings cash intakes cash out
Every line side by side 32 lines
Line Code 2024 2025 Change %
Total assets 20/58 €158,595 €272,827 +€114,232 +72.0%
Current assets 29/58 €158,595 €272,827 +€114,232 +72.0%
Stocks and contracts in progress 3 €35,381 €15,392 -€19,989 -56.5%
Stocks 30/36 €35,381 €15,392 -€19,989 -56.5%
Amounts receivable within one year 40/41 €88,000 €257,090 +€169,090 +192%
Trade receivables 40 - €47,140 +€47,140
Other amounts receivable 41 €88,000 €209,950 +€121,950 +139%
Cash at bank and in hand 54/58 €29,364 €345 -€29,019 -98.8%
Deferred charges and accrued income 490/1 €5,850 €0 -€5,850 -100%
Total equity and liabilities 10/49 €158,595 €272,827 +€114,232 +72.0%
Equity 10/15 €11,300 €15,024 +€3,724 +33.0%
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 €1,300 €5,024 +€3,724 +286%
Amounts payable 17/49 €147,295 €257,803 +€110,508 +75.0%
Amounts payable within one year 42/48 €21,862 €257,803 +€235,941 +1,079%
Trade debts 44 €12,547 €247,838 +€235,291 +1,875%
Suppliers 440/4 €12,547 €247,838 +€235,291 +1,875%
Taxes, remuneration and social security 45 €9,315 €9,965 +€650 +7.0%
Taxes 450/3 €9,315 €9,965 +€650 +7.0%
Accrued charges and deferred income 492/3 €125,433 €0 -€125,433 -100%
Other operating charges 640/8 - €707 +€707
Gross operating margin 9900 -€1,718 €4,288 +€6,006
Operating profit (loss) 9901 -€1,718 €3,580 +€5,298
Financial income 75/76B €2,172 €1,965 -€207 -9.5%
Recurring financial income 75 €2,172 €1,965 -€207 -9.5%
Non-recurring financial income 76B €2,172 €1,965 -€207 -9.5%
Financial charges 65/66B €284 €522 +€238 +83.8%
Recurring financial charges 65 €284 €522 +€238 +83.8%
Profit (loss) for the period before taxes 9903 €170 €5,024 +€4,854 +2,855%
Income taxes 67/77 - €1,299 +€1,299
Profit (loss) for the period 9904 €170 €3,725 +€3,555 +2,091%
Profit (loss) for the period to be appropriated 9905 €170 €3,725 +€3,555 +2,091%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.